ArticleJournal of conservative dentistry and endodontics2025
Comparative evaluation of cytotoxic effects of a new biomaterial nanohydroxyapatite-lactoferrin, nanohydroxyapatite, mineral trioxide aggregate, and calcium-enriched mixture on human dental pulp stem cells.
Article in Journal of conservative dentistry and endodontics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Evaluation of antimicrobial efficacy of mineral trioxide aggregate with and without silver nanoparticles: A systematic review and meta-analysis.Journal of conservative dentistry and endodontics · 2025Review
- Cytotoxicity of hydraulic cement dicalcium silicate mixture of eggshell calcium and rice husk silica on fibroblast cells.Journal of conservative dentistry and endodontics · 2025Article
- Effect of biodentine modified with bioactive glass nanoparticles on biocompatibility, osteogenic differentiation, and gene expression of human dental pulp stem cells.Journal of conservative dentistry and endodontics · 2025Article
- Cytotoxicity of chitosan-loaded triple antibiotic paste versus conventional triple antibiotic paste on dental pulp stem cells: AnJournal of conservative dentistry and endodontics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Regenerative therapies are emerging as promising alternatives to traditional dental treatments, aiming to preserve pulp vitality. Identifying an ideal biomaterial is crucial for the success of these therapies. Aims: This study is the first to evaluate and compare the toxicity of nanohydroxyapatite (NHA), NHA-lactoferrin (NHA-LF), calcium-enriched mixture (CEM), and mineral trioxide aggregate (MTA) on dental pulp stem cells. Materials and Methods: Hydroxyapatite nanocrystals were functionalized with LF in a HEPES buffer to create the NHA-LF combination. MTA, CEM, and NHA were prepared under sterile conditions. The cytotoxicity was evaluated using the MTT assay. Two-way ANOVA was used for data analysis. Games-Howell and Sidak tests were utilized for further analysis post-ANOVA. Results: The highest cytotoxicity was observed with NHA-LF at a 1000% concentration after 48 h, averaging 45.68%. In contrast, the lowest cytotoxicity was noted with MTA at a 10% concentration within 24 h, averaging 229.53%. There was a significant statistical relationship between substance type and cellular viability (P < 0.05), whereas time showed no significant impact (P > 0.05). Conclusion: The findings indicate a significant correlation between the type of biomaterial used and its effect on cellular proliferation and viability, with time showing no significant influence. All the tested materials can be categorized as noncytotoxic materials, except NHA-LF in the highest concentration (1000%). The study suggests prioritizing low-dose NHA-LF for use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.